Alzheimer’s disease is a major cause of dementia in the elderly.
The disease usually occurs gradually and becomes clinically apparent as a hidden disorder of intellectual functions, changes in behavior and mood. In the early stage of the disease, patients usually have difficulties in adopting new information or memory (eg. Where left the keys, wallet).
Then the problem becomes unable to retelling of past events and inability to convey. Being not advanced, memory loss and aphasia lead to severe cortical dysfunction, and over the next 5 to 10 years the patient becomes deeply invalid, deaf, immobile and unable to perform basic life functions provided.
Death usually occurs because of secondary infections or pneumonia dashed.
More than 50% greater among people over 85, but can occur in younger people.
There is evidence that there is inflammation in the brain of a patient with Alzheimer’s disease, which is associated with the formation of amyloid protein.
There is no cure for Alzheimer’s disease and treatment relies on relieving symptoms and slowing the progression of the disease. Medications that increase the concentration of acetylcholine are approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease.
Patients receiving drugs that cholinesterase inhibitors, which have a modest but positive effect particularly in the middle stage of the disease.